• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS INC. IMMULITE 2000 ANDROSTENEDIONE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS INC. IMMULITE 2000 ANDROSTENEDIONE Back to Search Results
Model Number IMMULITE 2000 ANDROSTENEDIONE
Device Problems Nonstandard Device (1420); High Test Results (2457)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 07/03/2013
Event Type  malfunction  
Event Description
The customer has obtained falsely high values on five patient samples for the androstenedione assay on an immulite 2000 instrument, when using reagent lot 315.The five patient samples were also run on an alternate platform where the results were lower.The last sample was retested on the immulite 2000 instrument using a heterophile blocking tube (hbt).The patient results from the immulite 2000 instrument were not released to the physician(s).It is unknown if the results from the alternate platform were released to the physician(s).There were no known reports of patient intervention or adverse health consequences due to the falsely high values obtained on the five patient samples when using reagent lot 315.
 
Manufacturer Narrative
Siemens has investigated the incidence of over recovery of patient samples and quality controls on the immulite/immulite1000 androstenedione assay lot number 409 and above, and immulite 2000/immulite 2000 xpi androstenedione assay lot number 314 and above.Siemens has confirmed that these lots are linear up to a concentration of 5.5 ng/ml, instead of the 10 ng/ml as stated in the instructions for use (ifu).Quality control materials at concentrations between 5.5 ng/ml and 10 ng/ml will detect this issue.An urgent medical device correction (umdc) 2013-12-19 was sent to us customers and an urgent field safety notice (ufsn) 4008 was sent to (b)(4) customers in december of 2013.The (b)(4) that customers are requested to use quality control materials with at least two levels having concentrations less than 5.5 ng/ml, and that patient values >5.5 ng/ml should be verified using an alternate method.
 
Manufacturer Narrative
The original mdr 2432235-2014-00032 was filed on january 8, 2014.Additional information (5/27/14): the over recovery and loss of linearity of the immulite systems androstenedione assay has been identified to be variability of a critical raw material (variation in the activity of rma160 alkaline phosphatase (unlabeled/low activity alkaline phosphatase, cold ap) in the reagent wedge).In addition, siemens healthcare sent out a customer bulletin 2014-05 in may 2014, announcing the restoration of the linearity of the androstenedione assay on the immulite 2000/immulite 2000 xpi to 10 ng/ml (35 nml/l), beginning with kit lot 331.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
IMMULITE 2000 ANDROSTENEDIONE
Type of Device
IMMULITE 2000 ANDROSTENEDIONE
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS INC.
glyn rhonwy
llanberis, caernarfon, gwynedd, wales LL55 4EL
UK  LL55 4EL
Manufacturer (Section G)
SIEMENS HEALTHCARE DIAGNOSTICS(REG#3002806944)
glyn rhowny
llanberis, caernarfon
gwynedd, wales LL5 4EL
UK   LL5 4EL
Manufacturer Contact
elizabeth beato
511 benedict avenue
tarrytown, NY 10591
9145243074
MDR Report Key3562244
MDR Text Key16448321
Report Number2432235-2014-00032
Device Sequence Number1
Product Code CIZ
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
EXEMPT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Health Professional
Remedial Action Recall
Type of Report Initial,Followup
Report Date 12/18/2013
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/08/2014
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other Health Care Professional
Device Model NumberIMMULITE 2000 ANDROSTENEDIONE
Device Catalogue NumberL2KAO
Device Lot Number315
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received05/27/2014
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Removal/Correction Number2432235-01/02/14-001-C
Patient Sequence Number1
-
-